Annual EBITDA
-$654.72 M
+$3.87 B+85.54%
31 December 2023
Summary:
Bio-Rad Laboratories annual earnings before interest, taxes, depreciation & amortization is currently -$654.72 million, with the most recent change of +$3.87 billion (+85.54%) on 31 December 2023. During the last 3 years, it has fallen by -$5.73 billion (-112.89%). BIO annual EBITDA is now -111.72% below its all-time high of $5.59 billion, reached on 31 December 2021.BIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$912.69 M
+$3.65 B+133.34%
30 September 2024
Summary:
Bio-Rad Laboratories quarterly earnings before interest, taxes, depreciation & amortization is currently $912.69 million, with the most recent change of +$3.65 billion (+133.34%) on 30 September 2024. Over the past year, it has increased by +$725.89 million (+388.59%). BIO quarterly EBITDA is now -81.95% below its all-time high of $5.06 billion, reached on 30 September 2021.BIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$806.52 M
+$725.89 M+47.37%
30 September 2024
Summary:
Bio-Rad Laboratories TTM earnings before interest, taxes, depreciation & amortization is currently -$806.52 million, with the most recent change of +$725.89 million (+47.37%) on 30 September 2024. Over the past year, it has dropped by -$812.27 million (-14133.79%). BIO TTM EBITDA is now -109.26% below its all-time high of $8.71 billion, reached on 30 September 2021.BIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.5% | +388.6% | -10000.0% |
| 3 y3 years | -112.9% | -82.0% | -109.3% |
| 5 y5 years | -197.0% | +408.4% | -218.9% |
BIO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -111.7% | +85.5% | -82.0% | +121.1% | -109.3% | +89.5% |
| 5 y | 5 years | -111.7% | +85.5% | -82.0% | +121.1% | -109.3% | +89.5% |
| alltime | all time | -111.7% | +85.5% | -82.0% | +121.1% | -109.3% | +89.5% |
Bio-Rad Laboratories EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $912.69 M(-133.3%) | -$806.52 M(-47.4%) |
| June 2024 | - | -$2.74 B(-606.5%) | -$1.53 B(+520.2%) |
| Mar 2024 | - | $540.46 M(+13.1%) | -$247.08 M(-62.3%) |
| Dec 2023 | -$654.72 M(-85.5%) | $477.95 M(+155.9%) | -$654.76 M(<-9900.0%) |
| Sept 2023 | - | $186.80 M(-112.9%) | $5.75 M(-101.7%) |
| June 2023 | - | -$1.45 B(-1193.9%) | -$342.41 M(+422.7%) |
| Mar 2023 | - | $132.77 M(-88.3%) | -$65.51 M(-98.6%) |
| Dec 2022 | -$4.53 B(-181.0%) | $1.14 B(-805.6%) | -$4.53 B(-40.9%) |
| Sept 2022 | - | -$161.35 M(-86.3%) | -$7.66 B(+214.0%) |
| June 2022 | - | -$1.18 B(-72.9%) | -$2.44 B(+3269.2%) |
| Mar 2022 | - | -$4.33 B(+117.7%) | -$72.38 M(-101.3%) |
| Dec 2021 | $5.59 B(+10.0%) | -$1.99 B(-139.3%) | $5.59 B(-35.8%) |
| Sept 2021 | - | $5.06 B(+324.6%) | $8.71 B(+62.0%) |
| June 2021 | - | $1.19 B(-10.5%) | $5.38 B(-1.7%) |
| Mar 2021 | - | $1.33 B(+17.7%) | $5.47 B(+7.7%) |
| Dec 2020 | $5.08 B(+110.0%) | $1.13 B(-34.4%) | $5.08 B(+8.3%) |
| Sept 2020 | - | $1.72 B(+34.0%) | $4.69 B(+75.7%) |
| June 2020 | - | $1.29 B(+37.1%) | $2.67 B(+21.8%) |
| Mar 2020 | - | $937.99 M(+26.8%) | $2.19 B(-9.4%) |
| Dec 2019 | $2.42 B(+258.5%) | $739.89 M(-350.0%) | $2.42 B(+256.6%) |
| Sept 2019 | - | -$295.99 M(-136.6%) | $678.20 M(-50.3%) |
| June 2019 | - | $808.64 M(-30.7%) | $1.37 B(+45.7%) |
| Mar 2019 | - | $1.17 B(-216.5%) | $937.10 M(+38.9%) |
| Dec 2018 | $674.72 M(+150.3%) | -$1.00 B(-355.8%) | $674.72 M(-61.9%) |
| Sept 2018 | - | $391.10 M(+2.8%) | $1.77 B(+22.0%) |
| June 2018 | - | $380.46 M(-57.9%) | $1.45 B(+30.2%) |
| Mar 2018 | - | $903.77 M(+857.1%) | $1.11 B(+313.4%) |
| Dec 2017 | $269.52 M(+29.7%) | $94.43 M(+31.6%) | $269.52 M(+44.8%) |
| Sept 2017 | - | $71.76 M(+62.5%) | $186.18 M(+2.7%) |
| June 2017 | - | $44.16 M(-25.4%) | $181.23 M(-12.5%) |
| Mar 2017 | - | $59.16 M(+433.4%) | $207.14 M(-0.3%) |
| Dec 2016 | $207.84 M(-30.6%) | $11.09 M(-83.4%) | $207.84 M(-28.5%) |
| Sept 2016 | - | $66.81 M(-4.7%) | $290.81 M(+0.7%) |
| June 2016 | - | $70.07 M(+17.1%) | $288.80 M(-2.2%) |
| Mar 2016 | - | $59.87 M(-36.4%) | $295.23 M(-1.4%) |
| Dec 2015 | $299.34 M(-1.4%) | $94.06 M(+45.2%) | $299.34 M(+1.2%) |
| Sept 2015 | - | $64.80 M(-15.3%) | $295.79 M(-0.8%) |
| June 2015 | - | $76.50 M(+19.6%) | $298.30 M(-4.5%) |
| Mar 2015 | - | $63.98 M(-29.3%) | $312.50 M(+2.9%) |
| Dec 2014 | $303.59 M(-5.4%) | $90.52 M(+34.5%) | $303.59 M(-1.0%) |
| Sept 2014 | - | $67.31 M(-25.8%) | $306.62 M(+1.3%) |
| June 2014 | - | $90.70 M(+64.7%) | $302.68 M(-1.6%) |
| Mar 2014 | - | $55.07 M(-41.1%) | $307.61 M(-4.1%) |
| Dec 2013 | $320.86 M(-22.0%) | $93.55 M(+47.6%) | $320.86 M(-4.4%) |
| Sept 2013 | - | $63.37 M(-33.7%) | $335.60 M(-9.6%) |
| June 2013 | - | $95.63 M(+40.0%) | $371.27 M(-3.7%) |
| Mar 2013 | - | $68.31 M(-36.9%) | $385.71 M(-5.4%) |
| Dec 2012 | $411.42 M(-2.0%) | $108.29 M(+9.3%) | $407.87 M(-4.8%) |
| Sept 2012 | - | $99.04 M(-10.0%) | $428.44 M(+0.1%) |
| June 2012 | - | $110.07 M(+21.7%) | $427.90 M(+2.5%) |
| Mar 2012 | - | $90.47 M(-29.8%) | $417.31 M(-0.6%) |
| Dec 2011 | $419.98 M(+6.9%) | $128.85 M(+30.8%) | $419.98 M(+5.6%) |
| Sept 2011 | - | $98.50 M(-1.0%) | $397.81 M(-0.0%) |
| June 2011 | - | $99.49 M(+6.8%) | $397.95 M(+0.9%) |
| Mar 2011 | - | $93.14 M(-12.7%) | $394.23 M(+0.3%) |
| Dec 2010 | $392.90 M(+17.4%) | $106.69 M(+8.2%) | $392.90 M(+6.1%) |
| Sept 2010 | - | $98.64 M(+3.0%) | $370.37 M(+1.8%) |
| June 2010 | - | $95.76 M(+4.3%) | $363.67 M(+3.0%) |
| Mar 2010 | - | $91.81 M(+9.1%) | $352.99 M(+5.5%) |
| Dec 2009 | $334.56 M(+23.0%) | $84.15 M(-8.5%) | $334.56 M(+17.3%) |
| Sept 2009 | - | $91.94 M(+8.1%) | $285.23 M(+5.7%) |
| June 2009 | - | $85.08 M(+15.9%) | $269.90 M(-1.6%) |
| Mar 2009 | - | $73.38 M(+110.7%) | $274.36 M(+0.8%) |
| Dec 2008 | $272.06 M(+78.5%) | $34.82 M(-54.6%) | $272.06 M(-2.0%) |
| Sept 2008 | - | $76.63 M(-14.4%) | $277.62 M(+9.7%) |
| June 2008 | - | $89.53 M(+26.0%) | $253.09 M(+18.4%) |
| Mar 2008 | - | $71.08 M(+76.0%) | $213.71 M(+9.1%) |
| Dec 2007 | $152.45 M(-33.6%) | $40.39 M(-22.5%) | $195.85 M(-12.6%) |
| Sept 2007 | - | $52.09 M(+3.9%) | $224.17 M(+3.9%) |
| June 2007 | - | $50.15 M(-5.8%) | $215.80 M(-2.9%) |
| Mar 2007 | - | $53.23 M(-22.5%) | $222.34 M(-3.1%) |
| Dec 2006 | $229.45 M(+30.1%) | $68.71 M(+57.2%) | $229.45 M(+15.3%) |
| Sept 2006 | - | $43.72 M(-22.9%) | $199.05 M(+2.0%) |
| June 2006 | - | $56.69 M(-6.0%) | $195.23 M(+7.6%) |
| Mar 2006 | - | $60.34 M(+57.5%) | $181.38 M(+2.9%) |
| Dec 2005 | $176.30 M(-1.5%) | $38.31 M(-4.0%) | $176.30 M(-3.3%) |
| Sept 2005 | - | $39.89 M(-6.9%) | $182.38 M(-0.0%) |
| June 2005 | - | $42.84 M(-22.5%) | $182.39 M(-1.9%) |
| Mar 2005 | - | $55.26 M(+24.5%) | $185.85 M(+3.8%) |
| Dec 2004 | $178.97 M | $44.39 M(+11.3%) | $178.97 M(+0.4%) |
| Sept 2004 | - | $39.90 M(-13.8%) | $178.23 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $46.30 M(-4.3%) | $182.74 M(-0.2%) |
| Mar 2004 | - | $48.37 M(+10.8%) | $183.17 M(-3.0%) |
| Dec 2003 | $189.43 M(+37.1%) | $43.66 M(-1.7%) | $188.85 M(+5.3%) |
| Sept 2003 | - | $44.41 M(-4.9%) | $179.41 M(-0.7%) |
| June 2003 | - | $46.72 M(-13.6%) | $180.72 M(+3.0%) |
| Mar 2003 | - | $54.06 M(+58.0%) | $175.50 M(+5.9%) |
| Dec 2002 | $138.19 M(-9.9%) | $34.22 M(-25.1%) | $165.70 M(-6.1%) |
| Sept 2002 | - | $45.72 M(+10.1%) | $176.54 M(+9.1%) |
| June 2002 | - | $41.51 M(-6.2%) | $161.82 M(+3.1%) |
| Mar 2002 | - | $44.26 M(-1.8%) | $156.96 M(-4.1%) |
| Dec 2001 | $153.33 M(+39.3%) | $45.06 M(+45.3%) | $163.63 M(+13.4%) |
| Sept 2001 | - | $31.00 M(-15.4%) | $144.35 M(+3.6%) |
| June 2001 | - | $36.64 M(-28.0%) | $139.29 M(+5.6%) |
| Mar 2001 | - | $50.93 M(+97.5%) | $131.94 M(+9.3%) |
| Dec 2000 | $110.08 M(+44.7%) | $25.78 M(-0.6%) | $120.76 M(+2.2%) |
| Sept 2000 | - | $25.94 M(-11.4%) | $118.17 M(+12.5%) |
| June 2000 | - | $29.29 M(-26.3%) | $105.03 M(+11.9%) |
| Mar 2000 | - | $39.75 M(+71.4%) | $93.84 M(+23.4%) |
| Dec 1999 | $76.09 M(+46.0%) | $23.19 M(+81.2%) | $76.03 M(+12.7%) |
| Sept 1999 | - | $12.80 M(-29.3%) | $67.45 M(+8.5%) |
| June 1999 | - | $18.09 M(-17.5%) | $62.15 M(+11.1%) |
| Mar 1999 | - | $21.94 M(+50.1%) | $55.96 M(+7.2%) |
| Dec 1998 | $52.12 M(+13.1%) | $14.62 M(+94.9%) | $52.22 M(+6.4%) |
| Sept 1998 | - | $7.50 M(-37.0%) | $49.10 M(-1.0%) |
| June 1998 | - | $11.90 M(-34.6%) | $49.60 M(0.0%) |
| Mar 1998 | - | $18.20 M(+58.3%) | $49.60 M(+7.1%) |
| Dec 1997 | $46.10 M(-19.0%) | $11.50 M(+43.8%) | $46.30 M(-1.1%) |
| Sept 1997 | - | $8.00 M(-32.8%) | $46.80 M(-10.0%) |
| June 1997 | - | $11.90 M(-20.1%) | $52.00 M(-3.7%) |
| Mar 1997 | - | $14.90 M(+24.2%) | $54.00 M(-5.6%) |
| Dec 1996 | $56.90 M(+0.9%) | $12.00 M(-9.1%) | $57.20 M(-3.5%) |
| Sept 1996 | - | $13.20 M(-5.0%) | $59.30 M(+1.9%) |
| June 1996 | - | $13.90 M(-23.2%) | $58.20 M(+1.2%) |
| Mar 1996 | - | $18.10 M(+28.4%) | $57.50 M(+2.1%) |
| Dec 1995 | $56.40 M(+5.4%) | $14.10 M(+16.5%) | $56.30 M(+1.1%) |
| Sept 1995 | - | $12.10 M(-8.3%) | $55.70 M(+1.3%) |
| June 1995 | - | $13.20 M(-21.9%) | $55.00 M(+0.4%) |
| Mar 1995 | - | $16.90 M(+25.2%) | $54.80 M(+2.4%) |
| Dec 1994 | $53.50 M(+98.1%) | $13.50 M(+18.4%) | $53.50 M(+18.6%) |
| Sept 1994 | - | $11.40 M(-12.3%) | $45.10 M(+13.0%) |
| June 1994 | - | $13.00 M(-16.7%) | $39.90 M(+17.4%) |
| Mar 1994 | - | $15.60 M(+205.9%) | $34.00 M(+26.4%) |
| Dec 1993 | $27.00 M(-4.9%) | $5.10 M(-17.7%) | $26.90 M(-10.9%) |
| Sept 1993 | - | $6.20 M(-12.7%) | $30.20 M(-2.6%) |
| June 1993 | - | $7.10 M(-16.5%) | $31.00 M(+29.7%) |
| Mar 1993 | - | $8.50 M(+1.2%) | $23.90 M(-16.1%) |
| Dec 1992 | $28.40 M(-17.0%) | $8.40 M(+20.0%) | $28.50 M(+3.3%) |
| Sept 1992 | - | $7.00 M(>+9900.0%) | $27.60 M(-4.2%) |
| June 1992 | - | $0.00(-100.0%) | $28.80 M(-20.9%) |
| Mar 1992 | - | $13.10 M(+74.7%) | $36.40 M(+6.4%) |
| Dec 1991 | $34.20 M(-1.4%) | $7.50 M(-8.5%) | $34.20 M(-9.0%) |
| Sept 1991 | - | $8.20 M(+7.9%) | $37.60 M(+3.9%) |
| June 1991 | - | $7.60 M(-30.3%) | $36.20 M(0.0%) |
| Mar 1991 | - | $10.90 M(0.0%) | $36.20 M(+4.3%) |
| Dec 1990 | $34.70 M(+19.7%) | $10.90 M(+60.3%) | $34.70 M(+13.8%) |
| Sept 1990 | - | $6.80 M(-10.5%) | $30.50 M(+3.4%) |
| June 1990 | - | $7.60 M(-19.1%) | $29.50 M(-0.7%) |
| Mar 1990 | - | $9.40 M(+40.3%) | $29.70 M(-61.2%) |
| Dec 1989 | $29.00 M(+10.7%) | $6.70 M(+15.5%) | $76.60 M(-237.0%) |
| Sept 1989 | - | $5.80 M(-25.6%) | -$55.90 M(+260.6%) |
| June 1989 | - | $7.80 M(-86.1%) | -$15.50 M(-160.3%) |
| Mar 1989 | - | $56.30 M(-144.8%) | $25.70 M(+29.1%) |
| Dec 1988 | $26.20 M(+21.9%) | -$125.80 M(-372.3%) | $19.90 M(-57.4%) |
| Sept 1988 | - | $46.20 M(-5.7%) | $46.70 M(+18.2%) |
| June 1988 | - | $49.00 M(-3.0%) | $39.50 M(+34.4%) |
| Mar 1988 | - | $50.50 M(-151.0%) | $29.40 M(+79.3%) |
| Dec 1987 | $21.50 M(+41.4%) | -$99.00 M(-353.8%) | $16.40 M(-52.7%) |
| Sept 1987 | - | $39.00 M(+0.3%) | $34.70 M(+29.5%) |
| June 1987 | - | $38.90 M(+3.7%) | $26.80 M(+38.9%) |
| Mar 1987 | - | $37.50 M(-146.5%) | $19.30 M(+63.6%) |
| Dec 1986 | $15.20 M(+42.1%) | -$80.70 M(-359.5%) | $11.80 M(-54.8%) |
| Sept 1986 | - | $31.10 M(-1.0%) | $26.10 M(+27.9%) |
| June 1986 | - | $31.40 M(+4.7%) | $20.40 M(+47.8%) |
| Mar 1986 | - | $30.00 M(-145.2%) | $13.80 M(+60.5%) |
| Dec 1985 | $10.70 M(+91.1%) | -$66.40 M(-361.4%) | $8.60 M(-51.1%) |
| Sept 1985 | - | $25.40 M(+2.4%) | $17.60 M(+43.1%) |
| June 1985 | - | $24.80 M(0.0%) | $12.30 M(+55.7%) |
| Mar 1985 | - | $24.80 M(-143.2%) | $7.90 M(+119.4%) |
| Dec 1984 | $5.60 M | -$57.40 M(-385.6%) | $3.60 M(-94.1%) |
| Sept 1984 | - | $20.10 M(-1.5%) | $61.00 M(+49.1%) |
| June 1984 | - | $20.40 M(-0.5%) | $40.90 M(+99.5%) |
| Mar 1984 | - | $20.50 M | $20.50 M |
FAQ
- What is Bio-Rad Laboratories annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual EBITDA year-on-year change?
- What is Bio-Rad Laboratories quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly EBITDA year-on-year change?
- What is Bio-Rad Laboratories TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM EBITDA year-on-year change?
What is Bio-Rad Laboratories annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BIO is -$654.72 M
What is the all time high annual EBITDA for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual earnings before interest, taxes, depreciation & amortization is $5.59 B
What is Bio-Rad Laboratories annual EBITDA year-on-year change?
Over the past year, BIO annual earnings before interest, taxes, depreciation & amortization has changed by +$3.87 B (+85.54%)
What is Bio-Rad Laboratories quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BIO is $912.69 M
What is the all time high quarterly EBITDA for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.06 B
What is Bio-Rad Laboratories quarterly EBITDA year-on-year change?
Over the past year, BIO quarterly earnings before interest, taxes, depreciation & amortization has changed by +$725.89 M (+388.59%)
What is Bio-Rad Laboratories TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BIO is -$806.52 M
What is the all time high TTM EBITDA for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM earnings before interest, taxes, depreciation & amortization is $8.71 B
What is Bio-Rad Laboratories TTM EBITDA year-on-year change?
Over the past year, BIO TTM earnings before interest, taxes, depreciation & amortization has changed by -$812.27 M (-14133.79%)